Clinical Trial Registries Expand: FDA Amendments of 2007

Practices: Health Care

Teleconference Overview

The FDA Amendments of 2007 have dramatically expanded the extent of information about clinical trial protocols, adverse events and results that must be publicly registered and publicly disclosed. These new measures will affect drug, device and biotechnology sponsors of clinical research and also will significantly affect investigator-initiated research at academic medical centers and medical schools. This audioconference will describe these changes in light of the history and nature of clinical trial registry requirements.

Cookie Settings